RCMI Coordinating Center (RCMI CC) Header Logo

Scott Widmann, PhD

Title
Faculty RankResearch Scientist
InstitutionTexas Southern University
DepartmentPharmaceutical Sciences
Address3100 Cleburne St
Houston TX 77004
Phone(713) 313-5641
ORCID ORCID Icon0000-0001-9889-0467 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Houston, Houston, TXPhD12/2022Cell and Molecular Biology

    Collapse Overview 
    Collapse overview
    My research is focused on drug discovery for cancer and infectious disease. I utilize computational methods, including AI/ML, bioinformatics, and virtual screening to identify targets, followed by experimental validation.

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Widmann S, Srivastava S, Lin CY. A Novel Liver X Receptor Inverse Agonist Impairs Cholesterol and Phospholipid Metabolism and Induces Apoptosis and Necroptosis in Pancreatic Ductal Adenocarcinoma Cells. Receptors. 2023; 2(1):34-46. View Publication.
    2. Srivastava S, Widmann S, Ho C, Nguyen D, Nguyen A, Premaratne A, Gustafsson J?, Lin CY. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells. Int J Mol Sci. 2020 Dec 17; 21(24). PMID: 33348693.
      Citations: 5     Fields:    Translation:HumansCells
    3. Karaboga H, Huang W, Srivastava S, Widmann S, Addanki S, Gamage KT, Mazhar Z, Ebalunode JO, Briggs JM, Gustafsson J?, Filgueira CS, Gilbertson SR, Lin CY. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. ACS Chem Biol. 2020 11 20; 15(11):2916-2928. PMID: 33074669.
      Citations: 5     Fields:    Translation:HumansCells
    4. Chaurasiya S, Widmann S, Botero C, Lin CY, Gustafsson J?, Strom AM. Estrogen receptor ? exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity. PLoS One. 2020; 15(5):e0226057. PMID: 32413024.
      Citations: 15     Fields:    Translation:HumansCells
    5. Phillips KN, Widmann S, Lai HY, Nguyen J, Ray JCJ, Bal?zsi G, Cooper TF. Diversity in lac Operon Regulation among Diverse Escherichia coli Isolates Depends on the Broader Genetic Background but Is Not Explained by Genetic Relatedness. mBio. 2019 11 12; 10(6). PMID: 31719176.
      Citations: 4     Fields:    Translation:Cells
    6. Peng F, Widmann S, W?nsche A, Duan K, Donovan KA, Dobson RCJ, Lenski RE, Cooper TF. Effects of Beneficial Mutations in pykF Gene Vary over Time and across Replicate Populations in a Long-Term Experiment with Bacteria. Mol Biol Evol. 2018 01 01; 35(1):202-210. PMID: 29069429.
      Citations: 15     Fields:    Translation:Cells
    Widmann's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (44)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support